Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity (2024)
- Authors:
- Chávez, Rocio Marisol Espinoza - Universidade Estadual de Campinas (UNICAMP)
- Rezende Junior, Celso de Oliveira - Universidade Estadual de Campinas (UNICAMP)
- Souza, Mariana Laureano de
- Pauli, Ivani
- Valli, Marilia
- Ferreira, Leonardo Luiz Gomes
- Chelucci, Rafael Consolin
- Duarte, Simone Michelan
- Krogh, Renata
- Silva, Fernando Bezerra Romualdo da - Universidade Federal de São Paulo (UNIFESP)
- Cruz, Fábio Cardoso - Universidade Federal de São Paulo (UNIFESP)
- Oliveira, Aldo Sena de - Universidade Federal de São Paulo (UNIFESP)
- Andricopulo, Adriano Defini
- Dias, Luiz Carlos - Universidade Estadual de Campinas (UNICAMP)
- Chávez, Rocio Marisol Espinoza - Universidade Estadual de Campinas (UNICAMP)
- USP affiliated authors: DUARTE, SIMONE MICHELAN - IFSC ; ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; VALLI, MARILIA - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC
- Unidade: IFSC
- DOI: 10.4155/fmc-2023-0185
- Subjects: FÁRMACOS; PLANEJAMENTO DE FÁRMACOS; DOENÇAS PARASITÁRIAS; DOENÇA DE CHAGAS; TRYPANOSOMA CRUZI
- Keywords: Chagas disease; N-imidazoylpiperazines; SAR; Trypanosoma cruzi; drug discovery; hit-to-lead
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 16, n. 3, p. 253-269, Jan. 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CHÁVEZ, Rocio Marisol Espinoza et al. Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity. Future Medicinal Chemistry, v. 16, n. Ja 2024, p. 253-269, 2024Tradução . . Disponível em: https://doi.org/10.4155/fmc-2023-0185. Acesso em: 27 abr. 2024. -
APA
Chávez, R. M. E., Rezende Junior, C. de O., Souza, M. L. de, Pauli, I., Valli, M., Ferreira, L. L. G., et al. (2024). Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity. Future Medicinal Chemistry, 16( Ja 2024), 253-269. doi:10.4155/fmc-2023-0185 -
NLM
Chávez RME, Rezende Junior C de O, Souza ML de, Pauli I, Valli M, Ferreira LLG, Chelucci RC, Duarte SM, Krogh R, Silva FBR da, Cruz FC, Oliveira AS de, Andricopulo AD, Dias LC. Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity [Internet]. Future Medicinal Chemistry. 2024 ; 16( Ja 2024): 253-269.[citado 2024 abr. 27 ] Available from: https://doi.org/10.4155/fmc-2023-0185 -
Vancouver
Chávez RME, Rezende Junior C de O, Souza ML de, Pauli I, Valli M, Ferreira LLG, Chelucci RC, Duarte SM, Krogh R, Silva FBR da, Cruz FC, Oliveira AS de, Andricopulo AD, Dias LC. Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity [Internet]. Future Medicinal Chemistry. 2024 ; 16( Ja 2024): 253-269.[citado 2024 abr. 27 ] Available from: https://doi.org/10.4155/fmc-2023-0185 - Indoles hit-to-lead for chagas disease: lessons learned within the LOLA consortium
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
- Antitrypanosomal Benzoxazinone series: hit-to-lead campaign and multiparametric optimization
- Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum
- Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies
- Synthesis of 1,2,3-triazole selenides with anti-T. cruzi activity
- SAR studies on a series of reversible competitive inhibitors of cruzain from Trypanosoma cruzi
- DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease
Informações sobre o DOI: 10.4155/fmc-2023-0185 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
